What is Capricor Therapeutics's stock option plan expense?

Capricor Therapeutics (CAPR) reported stock option plan expense of $5.92M in Q1 2026.

How has Capricor Therapeutics's stock option plan expense changed year-over-year?

Capricor Therapeutics's stock option plan expense increased by 8.0% year-over-year, from $5.48M to $5.92M.

Capricor Therapeutics CAPR Stock Option Plan Expense

Stock Option Plan Expense at other companies

CHE

ChemedCHE

$9.25M+1.7%

Global Net LeaseGNL

$4.04M+30.7%

TFX

TeleflexTFX

$2.5M—

ARD

Ardent Health PartnersARDT

$8.93M-3.6%

Lightwave Logic, Inc.LWLG

$331.53K-55.7%

UMH

UMH PropertiesUMH

$600K+20.0%

Other financials

Income statement

See full

Revenue--100%

Operating income-$36.8M-47.2%

Net income-$33.9M-39.2%

EPS (diluted)-$0.59-11.3%

Balance sheet

See full

Cash & equivalents$105.4M+266%

Total debt$14.8M+1,083%

Total equity$278.7M+118%

Total assets$326.3M+112%

Cash flow

See full

Operating cash flow-$29.3M-355%

CapEx$5.1M+472%

Free cash flow-$34.4M-369%

Valuation

See full

Market cap$1.71B+303%

Enterprise value$1.62B+308%

Profitability

See full

Operating margin-778.8%-1,038pp

Net margin-736.6%-981pp

FCF margin-563.9%-954pp

Returns & leverage

See full

Return on equity-56.4%-11.3pp

Debt / equity0.1×0.0×

Current ratio8.4×+1.9×

Where this comes from

Reported directly by Capricor Therapeutics in its filing.

Tagged under the XBRL concept us-gaap:StockOptionPlanExpense.

The official record: Capricor Therapeutics’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →

Ask your AI about Capricor Therapeutics's stock option plan expense.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Capricor Therapeutics's stock option plan expense?: Capricor Therapeutics (CAPR) reported stock option plan expense of $5.92M in Q1 2026.
How has Capricor Therapeutics's stock option plan expense changed year-over-year?: Capricor Therapeutics's stock option plan expense increased by 8.0% year-over-year, from $5.48M to $5.92M.